 | • レポートコード：MRC2304J0074 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、243ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、世界のヒト肝臓モデル市場規模は、2021年1,812.28百万ドルから2022年に2,025.82百万ドルへと拡大、その後2027年までに年平均11.95％成長して3,569.37百万ドルに達する見通しです。本書は、ヒト肝臓モデルの世界市場を対象とした調査・分析結果を整理したものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（2Dモデル、3Dバイオプリンティング、肝臓オルガノイド）、用途別分析（薬物送達、教育）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目を掲載しています。なお、本書には、BioIVT LLC、Biopredic International、CELLINK GLOBAL、CN Bio Innovations、Cyfuse Biomedical K.K.、Emulate Inc.、HµREL Corporation、InSphero AG、MIMETAS B.V.、NeurOmics, Inc.、Organovo Holdings Inc、STEMCELL Technologies Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のヒト肝臓モデル市場規模：製品別 - 2Dモデルの市場規模 - 3Dバイオプリンティングの市場規模 - 肝臓オルガノイドの市場規模 ・世界のヒト肝臓モデル市場規模：用途別 - 薬物送達における市場規模 - 教育における市場規模 ・世界のヒト肝臓モデル市場規模：地域別 - 南北アメリカのヒト肝臓モデル市場規模 アメリカのヒト肝臓モデル市場規模 カナダのヒト肝臓モデル市場規模 ブラジルのヒト肝臓モデル市場規模 ... - アジア太平洋のヒト肝臓モデル市場規模 日本のヒト肝臓モデル市場規模 中国のヒト肝臓モデル市場規模 インドのヒト肝臓モデル市場規模 韓国のヒト肝臓モデル市場規模 台湾のヒト肝臓モデル市場規模 ... - ヨーロッパ/中東/アフリカのヒト肝臓モデル市場規模 イギリスのヒト肝臓モデル市場規模 ドイツのヒト肝臓モデル市場規模 フランスのヒト肝臓モデル市場規模 ロシアのヒト肝臓モデル市場規模 ... - その他地域のヒト肝臓モデル市場規模 ・競争状況 ・企業情報 |
The Global Human Liver Model Market size was estimated at USD 1,812.28 million in 2021 and expected to reach USD 2,025.82 million in 2022, and is projected to grow at a CAGR 11.95% to reach USD 3,569.37 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Human Liver Model to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across 2D Models, 3D Bio Printing, and Liver Organoids.
Based on Application, the market was studied across Drug Discovery and Education.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Human Liver Model market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Human Liver Model Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Human Liver Model Market, including BioIVT LLC, Biopredic International, CELLINK GLOBAL, CN Bio Innovations, Cyfuse Biomedical K.K., Emulate Inc., HµREL Corporation, InSphero AG, MIMETAS B.V., NeurOmics, Inc., Organovo Holdings Inc, STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Human Liver Model Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Liver Model Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Liver Model Market?
4. What is the competitive strategic window for opportunities in the Global Human Liver Model Market?
5. What are the technology trends and regulatory frameworks in the Global Human Liver Model Market?
6. What is the market share of the leading vendors in the Global Human Liver Model Market?
7. What modes and strategic moves are considered suitable for entering the Global Human Liver Model Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence rate of non-alcoholic fatty liver disease
5.1.1.2. Emerging 3D and 2D trends in modeling human liver disease in vitro
5.1.1.3. Rising initiatives and awareness about liver organoids
5.1.2. Restraints
5.1.2.1. Lack of skilled and trained professionals
5.1.3. Opportunities
5.1.3.1. Growing focus on drug discovery activities
5.1.3.2. Potential growth of healthcare in the Asia Pacific and Latin America
5.1.4. Challenges
5.1.4.1. Generation of complex human organoid models
5.2. Cumulative Impact of COVID-19
6. Human Liver Model Market, by Product
6.1. Introduction
6.2. 2D Models
6.3. 3D Bio Printing
6.4. Liver Organoids
7. Human Liver Model Market, by Application
7.1. Introduction
7.2. Drug Discovery
7.3. Education
8. Americas Human Liver Model Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Human Liver Model Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Human Liver Model Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. BioIVT LLC
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Biopredic International
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. CELLINK GLOBAL
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. CN Bio Innovations
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Cyfuse Biomedical K.K.
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Emulate Inc.
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. HµREL Corporation
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. InSphero AG
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. MIMETAS B.V.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. NeurOmics, Inc.
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Organovo Holdings Inc
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. STEMCELL Technologies Inc.
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Thermo Fisher Scientific Inc.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. ZenBio, Inc.
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing